Real-time enrollment status for this ovarian cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 1:39 PM UTC
| NCT Number | NCT06315491 |
| Recruiting Status | Recruiting |
| Condition | Ovarian Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 60 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Cybrexa Therapeutics |
| Last Updated on CT.gov | October 6, 2025 (Oct 6, 2025) |
As of March 2, 2026: Clinical trial NCT06315491 is currently recruiting participants. This clinical trial study for ovarian cancer is actively seeking new participants at 20 locations across the United States. The study is sponsored by Cybrexa Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06315491 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06315491 was last updated Oct 6, 2025 (October 6, 2025). HelloStudys verifies this status automatically.